Efficacy of LCS compared with manual techniques

Article

Cost remains a large disadvantage to femtosecond laser cataract surgery

Femtosecond laser technology

The advancement in Femtosecond lasers has been remarkable, though debate continues about whether to become involved with the technology based on clinical efficacy and safety. The Catalys laser (Optimedica, Sunnyvale, California, USA) that our practice acquired in April 2012 has since had multiple upgrades - in particular improving power efficiency and accuracy. The most recent upgrade has reduced anterior capsulotomy time to less than 2 seconds, provided corneal incisions and dramatically reduced lens fragmentation times as well as enhancing the treatment zone. These improvements highlight that this technology has not yet reached maturity.

Another safety feature of the platform is the liquid optics interface, which causes only a small and transient rise in IOP.1 This is important for our elderly cataract patients who have significant co-morbidities such as glaucoma.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.